首页> 美国政府科技报告 >C-7 Progesterone Analogues and MDR1 in Breast Cancer
【24h】

C-7 Progesterone Analogues and MDR1 in Breast Cancer

机译:C-7孕酮类似物和mDR1在乳腺癌中的应用

获取原文

摘要

We have generated novel analogs of progesterone (PgA) as potent inhibitors of the MDR1 multidrug resistant phenotype in breast cancer. The objectives of this Research Project include the optimization of the PgA's MDR1- reversing activity through the generation of additional compounds, using an analog design approach, the definition of these compounds' in vivo efficacy, and of their mechanism of action. In the course of the fourth year of the Project, we have: (1) tested the in vivo MDR-reversing activity of PgA4, the most potent among our initial progesterone analogs; (2) designed and synthesized additional progesterone analogs and evaluated their structure-activity relationships; (3) related the in vitro activity of some of the analogs to their in vitro toxicity.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号